zur Startseite
 

Waldenstrom’s macroglobulinemia

Waldenstrom’s macroglobulinemia (WM) is very distinct from other indolent lymphoma subtypes: by definition it is accompanied by a monoclonal IgM gammopathy, it presents always with bone marrow infiltration and often with clinical symptoms such as neuropathy or hyperviscosity. These disease characteristics and the frequently advanced age of the WM patient pose a major challenge to the treating clinician even today.
Contact
Comprehensive Cancer Center Ulm
University Hospital Ulm
Prof. Dr. C. Buske
 
Phone:     +49 (0) 731 - 500 65801
Fax:     +49 (0) 731 - 500 65822
 
Dates
Thursday,

Veranstaltung

Veranstalter, Ort
News/Publications

Systematic Literature Review of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia - Need for a Disease-Specific Tool.

Bristogiannis, Sotirios, Jahanzaib Khwaja, Yadanar Lwin, Encarl Uppal, Shirley D'Sa, and Charalampia Kyriakou. eJHaem n/a, no. n/a
read more ›
 

Plain Language Summary of the Innovate Study: Ibrutinib Plus Rituximab Is Well-Tolerated and Effective in People with Waldenström's Macroglobulinemia

Buske, C., A. Tedeschi, J. Trotman, R. García-Sanz, D. MacDonald, V. Leblond, B. Mahe, C. Herbaux, J. V. Matous, C. S. Tam, L. T. Heffner, M. Varettoni, M. L. Palomba, C. Shustik, E. Kastritis, S. P. Treon, J. Ping, B. Hauns, I. Arango-Hisijara, and M. A. Dimopoulos. Future Oncol (Feb 23 2023).
read more ›